ARDT vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and VCYT
Should you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
Ardent Health Partners vs. Its Competitors
Ardent Health Partners (NYSE:ARDT) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, media sentiment, risk, valuation, earnings and dividends.
Guardant Health received 279 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 89.66% of users gave Ardent Health Partners an outperform vote while only 71.76% of users gave Guardant Health an outperform vote.
Ardent Health Partners has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Ardent Health Partners, indicating that it is currently the more affordable of the two stocks.
92.6% of Guardant Health shares are owned by institutional investors. 1.7% of Ardent Health Partners shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, Guardant Health had 14 more articles in the media than Ardent Health Partners. MarketBeat recorded 17 mentions for Guardant Health and 3 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 1.23 beat Guardant Health's score of 0.63 indicating that Ardent Health Partners is being referred to more favorably in the media.
Ardent Health Partners has a net margin of 0.00% compared to Guardant Health's net margin of -59.05%. Ardent Health Partners' return on equity of 0.00% beat Guardant Health's return on equity.
Ardent Health Partners currently has a consensus price target of $20.67, indicating a potential upside of 53.88%. Guardant Health has a consensus price target of $53.29, indicating a potential upside of 6.19%. Given Ardent Health Partners' higher probable upside, research analysts clearly believe Ardent Health Partners is more favorable than Guardant Health.
Summary
Ardent Health Partners beats Guardant Health on 11 of the 18 factors compared between the two stocks.
Get Ardent Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ardent Health Partners Competitors List
Related Companies and Tools
This page (NYSE:ARDT) was last updated on 6/13/2025 by MarketBeat.com Staff
